News & Events

Press Releases

Salarius Pharmaceuticals Added to FTSE Global Micro Cap Index

Salarius Pharmaceuticals to Present at the Virtual Life Science Investor Forum

Salarius Pharmaceuticals to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference

Salarius Pharmaceuticals to Present at the Virtual Diamond Equity Research Emerging Growth Invitational

Events

Life Science Investor Forum

Sep 16

Listen to Webcast

H.C. Wainwright 23rd Annual Global Investment Conference

Sep 13 - Sep 15

Listen to Webcast

NobleCon17: Panel Discussion on Targeted Cancer Therapies

Jan 19 @ 8:35AM ET

Listen to Webcast

During the Noble Capital Markets’ 17th Annual Small & Microcap Investor Conference, Dr. Daniela Santiesteban, Director of Research and Business Development at Salarius Pharmaceuticals, will participate in a virtual panel discussion highlighting the future of targeted cancer therapies. The panel...

Biotech Showcase Digital

Jan 11 - Jan 15

https://informaconnect.com/biotech-showcase/registration-options/

In the News

The Clinical Trials Guru

David Arthur, Salarius CEO Speaks with Dan Sfera of The Clinical Trials Guru

Houston Business Journal

Salarius Pharmaceuticals raises millions for expanded clinical trial, moves office in TMC

15 Biotech Companies in Houston Making a Major Impact on Medicine

Empowered Patient Podcast

Targeting Epigenetic Causes of Ewing’s Sarcoma with David Arthur Salarius Pharmaceuticals on Empowered Patient Podcast with Karen Jagoda

Reportable News

Salarius During the JP Morgan Week – Attend the Biotech Showcase Presentation or Join the Live Webcast

Proactive Investors

Salarius Pharmaceuticals CEO talks through recent achievements for its lead cancer drug candidate